Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
Flavio Cadegiani
Topics & Concepts
SpironolactoneCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineRespiratory distressAcute respiratory distress2019-20 coronavirus outbreakRespiratory systemInternal medicineIntensive care medicineCardiologyAnesthesiaVirologyAldosteroneLungOutbreakInfectious disease (medical specialty)DiseaseHeart Rate Variability and Autonomic ControlElectrolyte and hormonal disordersCardiac Arrest and Resuscitation